Original Paper
Abstract
Background: Myalgic encephalomyelitis (ME), also referred to as chronic fatigue syndrome (CFS), is a complex illness that typically presents with disabling fatigue and cognitive and functional impairment. The etiology and management of ME/CFS remain contentious and patients often describe their experiences through social media.
Objective: We explored public discourse on Twitter (rebranded as X) to understand the concerns and priorities of individuals living with ME/CFS, with a focus on (1) the COVID-19 pandemic and (2) publication of the 2021 UK National Institute for Health and Care Excellence (NICE) guidelines on the diagnosis and management of ME/CFS.
Methods: We used the Twitter application programming interface to collect tweets related to ME/CFS posted between January 1, 2010, and January 30, 2024. Tweets were sorted into 3 chronological periods (pre–COVID-19 pandemic, post–COVID-19 pandemic, and post-UK 2021 NICE Guidelines publication). A Robustly Optimized Bidirectional Embedding Representations from Transformers Pretraining Approach (RoBERTa) language processing model was used to categorize the sentiment of tweets as positive, negative, or neutral. We identified tweets that mentioned COVID-19, the UK NICE guidelines, and key themes identified through latent Dirichlet allocation (ie, fibromyalgia, research, and treatment). We sampled 1000 random tweets from each theme to identify subthemes and representative quotes.
Results: We retrieved 906,404 tweets, of which 427,824 (47.2%) were neutral, 369,371 (40.75%) were negative, and 109,209 (12.05%) were positive. Over time, both the proportion of negative and positive tweets increased, and the proportion of neutral tweets decreased (P<.001 for all changes). Tweets mentioning fibromyalgia acknowledged similarities with ME/CFS, stigmatization associated with both disorders, and lack of effective treatments. Treatment-related tweets often described frustration with ME/CFS labeled as mental illness, dismissal of concerns by health care providers, and the need to seek out “good physicians” who viewed ME/CFS as a physical disorder. Tweets on research typically praised studies of biomarkers and biomedical therapies, called for greater investment in biomedical research, and expressed frustration with studies suggesting a biopsychosocial etiology for ME/CFS or supporting management with psychotherapy or graduated activity. Tweets about the UK NICE guidelines expressed frustration with the 2007 version that recommended cognitive behavioral therapy and graded exercise therapy, and a prolonged campaign by advocacy organizations to influence subsequent versions. Tweets showed high acceptance of the 2021 UK NICE guidelines, which were seen to validate ME/CFS as a biomedical disease and recommended against graded exercise therapy. Tweets about COVID-19 often noted overlaps between post–COVID-19 condition and ME/CFS, including claims of a common biological pathway, and advised there was no cure for either condition.
Conclusions: Our findings suggest research is needed to inform how best to support patients’ engagement with evidence-based care. Furthermore, while patient involvement with ME/CFS research is critical, unmanaged intellectual conflicts of interest may threaten the trustworthiness of research efforts.
doi:10.2196/65087
Keywords
Introduction
Background
Myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome (CFS) [
], is characterized by persistent fatigue, cognitive dysfunction, and impaired daily functioning [ ]. The global prevalence of ME/CFS has been estimated at 0.89% (95% CI 0.6%-1.33%), and it is more common among women aged 40 to 50 years [ ]. Despite the prevalence and debilitating nature of ME/CFS, it remains poorly understood due to uncertain pathophysiology, nonspecific symptoms, and limited education and acceptance by the medical community [ ].There have been 2 recent events that may have affected public perceptions toward ME/CFS. The first was the reversal of a 2007 clinical practice recommendation for use of graded exercise in the management of ME/CFS by the UK National Institute for Health and Care Excellence (NICE) in 2021. The original recommendation in favor of exercise was seen by some patient advocacy groups as stigmatizing their condition as psychosocial [
, ]. Second, the COVID-19 pandemic, and resulting millions of recovered patients who developed post–COVID19 condition (PCC; also known as “long COVID”), a condition with considerable overlap with ME/CFS [ ]. The emergence of PCC has reignited both research and clinical attention regarding postinfectious fatigue syndromes [ , ].Lived experiences are invaluable sources of information for guiding research [
], and people living with ME/CFS report higher levels of web-based activity compared with other patient groups [ , ]. Social media is highly valued among individuals with ME/CFS to connect with other patients [ ]. Data from social media have been used to model public sentiment and perceptions of health issues, especially relating to COVID-19 [ ] and PCC [ , ]. However, while studies have suggested similarities between PCC and ME/CFS [ , ], no study has specifically analyzed social media information on ME/CFS.To date, numerous frameworks for sentiment analysis have been explored [
, ]. Pretrained encoder transformers, such as Bidirectional Embedding Representations from Transformers (BERT) and its variants have demonstrated potential in accurate sentiment assessment due to sophisticated contextual understanding from multihead self-attention [ - ]. Furthermore, the transformer architecture significantly improves training efficiency, allowing for large pretrained models, and requires minimal preprocessing due to the ability of complex neural networks to automatically capture hidden patterns during training [ ].For topic modeling and thematic analysis, term frequency and latent Dirichlet allocation (LDA) have emerged as widely used approaches. Term frequency is a simple metric that quantifies how often a particular word appears in a dataset, providing insights into commonly discussed topics [
]. LDA is a generative probabilistic model that assumes each document is a mixture of topics, and each topic is characterized by a distribution of words [ ]. By uncovering these distributions, LDA groups terms with similar semantic meaning, making it easier to discern overarching topics and patterns and enabling researchers to identify latent themes within large text datasets [ ].This Study
To examine the public discourse on Twitter (rebranded as X in July 2023), we leveraged a BERT variant for sentiment analysis and term frequency and LDA for topic modeling and thematic analysis to understand the sentiments, concerns, and priorities of individuals living with ME/CFS and associated interest holders. By addressing these knowledge gaps, this study helps inform the use of social media analysis in understanding complex disorders, such as ME/CFS.
Methods
Overview
We conducted a retrospective observational study of tweets. Our research approach consisted of seven steps: (1) developing Twitter search terms, (2) establishing a period from which tweets would be collected, (3) using the Twitter application programming interface (API) to collect tweets within the defined search period, (4) processing tweets to enhance the accuracy of data analyses, (5) performing sentiment analysis using a Robustly Optimized BERT Pretraining Approach (RoBERTa), (6) identifying themes among tweets through word frequency, and (7) collecting and further analyzing 1000 random tweets for each theme to identify subthemes and representative quotes (
) [ ].
Data Collection
The search terms used to collect tweets were “me/cfs,” “myalgic encephalomyelitis/chronic fatigue syndrome,” “myalgic encephalomyelitis,” and “chronic fatigue syndrome.” We excluded non-English tweets and retweets.
The search period for tweet collection was January 1, 2010, to January 30, 2024. The full-archive search end point from the Twitter API allows users to retrieve publicly available tweets posted since March 2006 [
]. We were aware of 2 key events relevant to ME/CFS during our search period: the onset of the COVID-19 pandemic and subsequent recognition of PCC (which has substantial overlap with ME/CFS) [ ], and the release of the 2021 UK NICE guidelines for the diagnosis and management of ME/CFS [ ]. As such, we grouped retrieved tweets into the following three periods for analysis: (1) pre–COVID-19 pandemic (January 1, 2010, to December 11, 2019), (2) post–COVID-19 pandemic (December 12, 2019, to October 27, 2021), and (3) post-UK NICE guidelines publication (October 28, 2021, to January 30, 3024). December 11, 2019, was chosen as the last day of the pre–COVID-19 period as the first report of the SARS-CoV-2 virus was on December 12, 2019 [ ]. Similarly, October 28, 2021, was chosen as the first day to begin collecting tweets for the post-UK 2021 NICE guidelines publication dataset because the new guidelines were originally announced on that day, although they were officially published on October 29, 2021 [ ].Data Preprocessing
For our sentiment analysis, modifications to tweets included removal of URLs, hashtag symbols, and Twitter handle mentions. Emojis were converted to their textual representations as they convey sentiment. For topic modeling, URLs, hashtag symbols, Twitter handle mentions, emojis, and original search terms were removed, and all remaining words were uncased and lemmatized using wordnet part-of-speech tagging. Empty tweets were excluded from analysis.
Sentiment Analysis
We used the natural language processing (NLP) capabilities of RoBERTa to conduct sentiment analysis of the cleaned tweets. RoBERTa, an iteration of BERT, was selected over its predecessor due to its robust performance and notable effectiveness in understanding short-text formats, such as tweets [
- ]. RoBERTa was trained on approximately 58 million tweets and fine-tuned for sentiment analysis with the TweetEval benchmark [ ]. With Softmax activation for the dense output layer, RoBERTa generated probability scores for each tweet and categorized them into 3 mutually exclusive sentiment classes: negative, neutral, or positive. The difference between the proportion of sentiments across all possible comparison between the 3 periods (pre–COVID-19 pandemic vs post–COVID-19 pandemic, post–COVID-19 pandemic vs post-UK NICE guidelines publication, pre–COVID-19 pandemic vs post-UK NICE guidelines publication, and pre–COVID-19 pandemic vs post–COVID-19 pandemic vs post-UK NICE guidelines publication) were evaluated using a chi-square test, where P<.05 indicates statistical significance.Model Explainability
Model explainability for RoBERTa was assessed using Shapley Additive Explanations (SHAP) Partition Explainer [
- ]. SHAP values were computed for the predicted probability of each tweet individually. Subsequently, text features were uncased and trimmed to remove leading and trailing white spaces. The 15 most important positive and negative features by the mean SHAP values across different periods were presented. We analyzed unique text features with ≥100 occurrences.Topic Modeling
Topics across timeframes were modeled using LDA. The models were trained with 10 passes and a random seed of 42, and 6 topics were generated.
Identification of Tweet Themes
On the basis of key events during the search period, our research questions, and the most frequent terms—excluding words used in search terms, we identified themes to explore in the retrieved tweets. For each theme, the corresponding tweets were each assigned a unique number, and a random number generator (Microsoft Excel version 2406) was used to select a random sample of tweets. A preliminary coding scheme was developed through inductive coding of a random sample of 100 tweets for each theme. This exercise was completed independently by 5 analysts. After completion, a new random sample of 1000 tweets were acquired for each theme, and the coding scheme was applied to this sample independently by teams of 2 to 3 reviewers. Each team included a physician-in-training and a methodologist with training in qualitative research. The research team met throughout the coding process to discuss and revise the coding scheme, as necessary. Subthemes represented in fewer than 20 tweets were discarded. Reviewers discussed any discrepancies to achieve consensus.
Hardware and Software
All SHAP values were calculated in parallel using multiple NVIDIA V100 Volta (32G HBM2 memory) each with 8 central processing unit threads and 40 GB of system memory provided by the Digital Alliance of Canada. All other analyses were conducted using an NVIDIA RTX 2070 (8 GB graphics double data rate 6 [GDDR6] memory) with 32 central processing unit threads and 64 GB of system memory.
The unprocessed dataset and accompanying code are available on the web [
]. Tweets were queried and fetched using tweepy and the GET/2/tweets/search/all end point in Twitter API (version 2). Data management and preprocessing were handled with pandas, re, and nltk. Sentiment analysis was performed using Hugging Face transformers, while shap provided interpretability insights. Statistical analyses leveraged numpy, scipy, statsmodels, and sklearn. For topic modeling, the genism library was used. All visualizations were generated with matplotlib and seaborn. Twitter thematic analysis was completed using Microsoft Excel.Ethical Considerations
This study ensured anonymity and confidentiality of Twitter users by removing the Twitter handles associated with all representative tweets reported. The requirement for ethics review was waived by the Hamilton Integrated Research Ethics Board at McMaster University because all tweets were publicly available.
Results
Characteristics of the Dataset
After processing, the Twitter API retrieved 906,404 tweets relevant to ME/CFS during our search period. This included 570,723 (62.96%) tweets spanning from January 1, 2010, to December 11, 2019 (pre–COVID-19 pandemic group); 139,486 (15.38%) tweets spanning from December 12, 2019, to October 27, 2021 (post–COVID-19 pandemic group); and 196,195 (21.64%) tweets spanning from October 28, 2021, to January 30, 2024 (post-UK NICE guidelines publication group).
Sentiment Analysis
Overall, tweets related to ME/CFS were predominantly neutral (n=427,824, 47.2%) or negative (n=369,371, 40.8%), with only 12% of tweets (n=109,209) classified as conveying positive sentiments (
). Over the 3 periods of interest, we found the proportion of negative tweets increased from 36.7% to 49.9%, the proportion of positive tweets increased from 11.1% to 14.3%, and neutral tweets decreased. Differences in sentiment proportions were significantly different across all comparisons (P<.001).Period | Positive tweets, n (%) | Neutral tweets, n (%) | Negative tweets, n (%) |
Pre–COVID-19 pandemic (n=570,723) | 63,094 (11.1) | 298,411 (52.3) | 209,218 (36.7) |
Post–COVID-19 pandemic (n=139,486) | 17,983 (12.9) | 59,173 (42.4) | 62,330 (44.7) |
Post-UK NICE guidelines publication (n=196,195) | 28,132 (14.3) | 70,240 (35.8) | 97,823 (49.9) |
Total (N=906,404) | 109,209 (12) | 427,824 (47.2) | 369,371 (40.8) |
Model Explanations
Across all periods, the importance of 99,231,570 individual features were analyzed, of which 29,558 (0.03%) were unique and 8872 (0.009%) demonstrated 100 or more occurrences. The top 15 most important features by the mean SHAP values for each sentiment are presented in
. Tokens, such as “excited,” “enjoyed,” and “appreciate” increased the probability of positive sentiment and decreased the probability of neutral and negative sentiments. Tokens with obvious negative connotations, including “disgusting,” “sucks,” and “horrible” increased negative sentiment probabilities. Explanations tweets across different periods are provided in Figures S1-S18 in . Sentimentally important features were similar across different periods.Token features | SHAP value, mean (95% CI) | ||
Positive features for positive sentiment | |||
excited | 0.480 (0.467 to 0.493) | ||
exciting | 0.432 (0.418 to 0.446) | ||
enjoyed | 0.367 (0.339 to 0.394) | ||
appreciate | 0.314 (0.306 to 0.323) | ||
congratulations | 0.297 (0.279 to 0.314) | ||
appreciated | 0.286 (0.275 to 0.297) | ||
delighted | 0.272 (0.253 to 0.291) | ||
enjoying | 0.268 (0.244 to 0.291) | ||
lovely | 0.251 (0.242 to 0.26) | ||
excellent | 0.231 (0.225 to 0.237) | ||
liked | 0.226 (0.221 to 0.232) | ||
blessed | 0.226 (0.205 to 0.247) | ||
proud | 0.218 (0.208 to 0.227) | ||
beautiful | 0.216 (0.205 to 0.227) | ||
thankful | 0.212 (0.197 to 0.227) | ||
Negative features for positive sentiment | |||
bye | –0.082 (–0.094 to –0.069) | ||
deprived | –0.072 (–0.075 to –0.07) | ||
sucks | –0.056 (–0.058 to –0.053) | ||
disgusting | –0.048 (–0.053 to –0.043) | ||
scandals | –0.047 (–0.051 to –0.043) | ||
horrible | –0.043 (–0.045 to –0.041) | ||
iful | –0.042 (–0.054 to –0.031) | ||
frustrating | –0.040 (–0.042 to –0.038) | ||
suck | –0.040 (–0.044 to –0.036) | ||
unacceptable | –0.040 (–0.043 to –0.036) | ||
terrible | –0.039 (–0.041 to –0.038) | ||
suicide | –0.039 (–0.04 to –0.038) | ||
clar | –0.038 (–0.041 to –0.036) | ||
disappointed | –0.038 (–0.041 to –0.035) | ||
sco | –0.038 (–0.043 to –0.033) | ||
Positive features for neutral sentiment | |||
smithsonian | 0.100 (0.095 to 0.105) | ||
ashton | 0.094 (0.089 to 0.099) | ||
spotify | 0.085 (0.084 to 0.086) | ||
venture | 0.080 (0.073 to 0.087) | ||
insp | 0.077 (0.074 to 0.079) | ||
antioxidants | 0.075 (0.067 to 0.083) | ||
beetles | 0.071 (0.07 to 0.071) | ||
safely | 0.070 (0.07 to 0.071) | ||
praise | 0.066 (0.061 to 0.07) | ||
announces | 0.064 (0.061 to 0.067) | ||
embracing | 0.063 (0.062 to 0.064) | ||
playlist | 0.063 (0.06 to 0.066) | ||
winston | 0.062 (0.061 to 0.062) | ||
listener | 0.061 (0.061 to 0.062) | ||
churchill | 0.060 (0.059 to 0.06) | ||
Negative features for neutral sentiment | |||
disgusting | –0.378 (–0.395 to –0.361) | ||
excited | –0.344 (–0.357 to –0.33) | ||
sucks | –0.334 (–0.341 to –0.327) | ||
shameful | –0.322 (–0.329 to –0.314) | ||
unacceptable | –0.313 (–0.331 to –0.294) | ||
horrible | –0.311 (–0.317 to –0.304) | ||
embarrassing | –0.307 (–0.328 to –0.287) | ||
disgrace | –0.305 (–0.323 to –0.288) | ||
exciting | –0.301 (–0.314 to –0.287) | ||
bullshit | –0.286 (–0.296 to –0.277) | ||
terrible | –0.286 (–0.291 to –0.28) | ||
unbelievable | –0.280 (–0.297 to –0.264) | ||
ridiculous | –0.275 (–0.282 to –0.269) | ||
disappointed | –0.271 (–0.284 to –0.258) | ||
unbearable | –0.268 (–0.286 to –0.25) | ||
Positive features for negative sentiment | |||
disgusting | 0.426 (0.407 to 0.445) | ||
sucks | 0.389 (0.381 to 0.397) | ||
horrible | 0.354 (0.347 to 0.361) | ||
shameful | 0.354 (0.346 to 0.362) | ||
unacceptable | 0.352 (0.333 to 0.371) | ||
disgrace | 0.343 (0.324 to 0.361) | ||
embarrassing | 0.342 (0.32 to 0.364) | ||
terrible | 0.325 (0.319 to 0.331) | ||
bullshit | 0.320 (0.31 to 0.331) | ||
unbelievable | 0.314 (0.296 to 0.331) | ||
disappointed | 0.309 (0.295 to 0.323) | ||
ridiculous | 0.306 (0.299 to 0.314) | ||
unbearable | 0.301 (0.281 to 0.321) | ||
suck | 0.292 (0.274 to 0.31) | ||
stupid | 0.291 (0.283 to 0.299) | ||
Negative features for negative sentiment | |||
liked | –0.184 (–0.189 to –0.179) | ||
blessed | –0.146 (–0.161 to –0.13) | ||
enjoyed | –0.142 (–0.155 to –0.13) | ||
excited | –0.136 (–0.141 to –0.132) | ||
appreciate | –0.136 (–0.14 to –0.133) | ||
exciting | –0.131 (–0.136 to –0.126) | ||
bless | –0.121 (–0.126 to –0.115) | ||
enjoying | –0.117 (–0.129 to –0.105) | ||
appreciated | –0.115 (–0.12 to –0.111) | ||
insp | –0.112 (–0.116 to –0.108) | ||
thankful | –0.109 (–0.115 to –0.102) | ||
delighted | –0.107 (–0.114 to –0.101) | ||
proud | –0.106 (–0.11 to –0.102) | ||
lovely | –0.106 (–0.11 to –0.102) | ||
excellent | –0.104 (–0.106 to –0.101) |
Topic Modeling
The 6 modeled topics across all tweets are presented in
. We categorized topic A as treatment based on the frequency of terms, such as “study,” “patient,” “drug,” and “treatment.” Similarly, topic D related to research advocacy due to the appearance of terms such as “research,” “aid,” “funding,” “NIH” (which refers to National Institutes of Health), and “CDC” (which refers to Centers for Disease Control and Prevention), the latter of which refer to public health agencies of the United States and United Kingdom that allocate research funding. In addition, the appearance of the term “pwme” refers to an acronym which stands for “people with myalgic encephalomyelitis,” a common tag used in online support circles among those with ME/CFS. Topic B suggested a focus on symptoms and information resources and mentions terms such as “fatigue,” “Amazon,” “Kindle,” “bestseller,” “book,” and “story.” Topics C and E referred to fibromyalgia and PCC, respectively due to the most heavily-weighted terms in each category being the names of these conditions. Finally, topic F related to symptoms and causes, including terms, such as “tire,” “always,” “virus,” and “disease.”Modeled topics across individual periods are presented in Figures S19-S36 in
. Before the COVID-19 pandemic, the most common comorbidity term was “fibromyalgia,” whereas during and after the pandemic, “long” and “COVID” appeared frequently. After publication of the updated NICE guideline for diagnosis and management of ME/CFS, terms such as “guideline,” “exercise,” “NICE,” “GET” (which refers to graded exercise therapy), and “CBT” (which refers to cognitive behavioral therapy) appeared.Word | Weight | ||
Treatment | |||
study | 0.02052 | ||
patient | 0.01787 | ||
treatment | 0.01541 | ||
use | 0.01179 | ||
link | 0.00987 | ||
fibromyalgia | 0.00930 | ||
drug | 0.00787 | ||
support | 0.00784 | ||
new | 0.00727 | ||
virus | 0.00613 | ||
test | 0.00601 | ||
community | 0.00599 | ||
group | 0.00599 | ||
found | 0.00578 | ||
research | 0.00578 | ||
Symptoms and resources | |||
symptom | 0.02825 | ||
fatigue | 0.02036 | ||
coverup | 0.01799 | ||
epidemic | 0.01510 | ||
amazon | 0.01425 | ||
kindle | 0.01412 | ||
chronic | 0.01391 | ||
aid | 0.01251 | ||
treatment | 0.01121 | ||
disease | 0.01118 | ||
bestseller | 0.01079 | ||
book | 0.00786 | ||
via | 0.00783 | ||
gut | 0.00780 | ||
story | 0.00771 | ||
Fibromyalgia | |||
fibromyalgia | 0.03497 | ||
fatigue | 0.02597 | ||
chronic | 0.02349 | ||
health | 0.01455 | ||
fm | 0.01441 | ||
syndrome | 0.01419 | ||
help | 0.01180 | ||
report | 0.01157 | ||
free | 0.01099 | ||
stress | 0.01094 | ||
exercise | 0.01026 | ||
may | 0.01022 | ||
recovery | 0.00954 | ||
therapy | 0.00935 | ||
via | 0.00909 | ||
Research | |||
research | 0.03034 | ||
pwme | 0.01996 | ||
new | 0.01762 | ||
disease | 0.01148 | ||
5 | 0.01090 | ||
myalgice | 0.01002 | ||
step | 0.00940 | ||
aid | 0.00815 | ||
nih | 0.00760 | ||
funding | 0.00721 | ||
cdc | 0.00690 | ||
read | 0.00613 | ||
book | 0.00609 | ||
deal | 0.00593 | ||
dr | 0.00588 | ||
Post–COVID-19 Condition | |||
covid | 0.01770 | ||
long | 0.01667 | ||
people | 0.01476 | ||
get | 0.01284 | ||
like | 0.01103 | ||
year | 0.00882 | ||
say | 0.00817 | ||
patient | 0.00800 | ||
would | 0.00794 | ||
know | 0.00708 | ||
many | 0.00682 | ||
make | 0.00679 | ||
thing | 0.00653 | ||
think | 0.00651 | ||
one | 0.00639 | ||
Symptoms and causes | |||
may | 0.02335 | ||
tire | 0.01935 | ||
always | 0.01785 | ||
know | 0.01399 | ||
news | 0.01352 | ||
get | 0.01011 | ||
people | 0.00925 | ||
cause | 0.00910 | ||
bubblews | 0.00851 | ||
learn | 0.00834 | ||
virus | 0.00751 | ||
help | 0.00735 | ||
million | 0.00726 | ||
day | 0.00691 | ||
disease | 0.00607 |
Twitter Thematic Analysis
Overview
The following five themes were identified for further thematic analysis: (1) fibromyalgia, (2) treatment, (3) research, (4) UK NICE guidelines for diagnosis and management of ME/CFS, and (5) PCC. We retrieved 2.59% (23,477/906,404) tweets that mentioned fibromyalgia; 1.78% (16,112/906,404) tweets about treatment; 4.18% (37,915/906,404) tweets about research; 0.3% (2234/906,404) tweets that discussed the UK NICE guideline for diagnosis and management of ME/CFS; and 8.9% (80,685/906,404) tweets pertaining to PCC. Notably, tweets could contribute to multiple themes.
Theme 1: Fibromyalgia
Fibromyalgia was a dominant topic that appeared in the LDA topic modeling, and our review of representative tweets identified 6 subthemes (Table S1 in
). The first 2 subthemes centered on patients’ frustration with categorization of ME/CFS and fibromyalgia as psychological or psychosomatic illnesses and disappointment with the care they received. Many tweets under these themes involved negative personal experiences with friends, family, or health care providers, including dismissal of ME/CFS and fibromyalgia-related symptoms:I can’t even count how many conversations I overheard between my parents during the 90s about how chronic fatigue syndrome and fibromyalgia were fake diseases for depressed, lazy, overweight, listless women with no other conflicts in their lives.
Doctors are so afraid of patients who have symptoms of FMG (fibromyalgia) or CFS (chronic fatigue syndrome) because they have no clue what are causes or how to treat. I now believe years of shots may be part of the causes.
That’s one thing I’m dealing with. One doctor said fibromyalgia. Another said fibromyalgia and chronic fatigue syndrome. Others look at me like I’m crazy. All I know is, I hurt all the time and I’m always tired. I’m just sick of them not listening.
The third subtheme focused on the dissemination of research investigating ME/CFS and fibromyalgia. Some tweets simply shared links to research articles on ME/CFS and fibromyalgia. Others lamented the lack of research toward these syndromes:
I think you are all on the back foot as researchers for long Covid as the similarities to the extremely underfunded chronic fatigue syndrome and related fibromyalgia conditions are completely inadequately diagnosed and treated. You have a long, long way to go to understanding.
The fourth subtheme included tweets specifically related to individuals sharing their personal experiences with ME/CFS and fibromyalgia, whereas the fifth subtheme included tweets that highlighted online support groups or educational resources for individuals with these conditions:
Jump ahead five years, I had lost over 50 pounds, was almost completely bedridden, and was too weak to sit up, talk, or feed myself. I was diagnosed with fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome, two illnesses that we still know very little about.
I got ME/CFS in the ’90s, and it turned into fibromyalgia in 2002. (Fibro is like ME/CFS with a lot more pain.) I stopped having severe pain that required opiates several years ago, but I’m still not healthy. I wouldn’t wish it on my worst enemy.
Check out FibroFlutters - an informal “patient-led” support group based in Sunderland for people with Fibromyalgia, ME/CFS, chronic illness.
The sixth subtheme focused on recommended treatments for fibromyalgia and ME/CFS symptom management. Tweets would often reference news articles supporting the claims being discussed, with many recommending unconventional treatment modalities:
Could Green Light Therapy Help Fibromyalgia and ME/CFS?
A Methylene Blue Boost? Could a Blue Dye Help with ME/CFS, Long COVID and Fibromyalgia?
Theme 2: Treatment
In total, 4 subthemes were identified on the topic of treatment for ME/CFS (Table S2 in
). The first subtheme was that most physicians are misinformed or do more harm than good. Many tweets expressed frustration with the fact that physicians typically lacked sufficient knowledge and experience to handle the complex, multifaceted symptomology associated with ME/CFS:It’s because regular doctors have no clue what post viral fatigue or ME/CFS is. Exercise can be harmful even if organs are fine.
I just LOVE idiot doctors who think they know more about ME/CFS than I do. None of them understand PEM [postexertional malaise], and always think I’m exaggerating. I have 40 years of experience with this, and they’re all morons.
The second related subtheme centered on physicians mislabeling ME/CFS as mental illness. Some tweets relayed experiences of physicians ascribing ME/CFS symptoms to major depressive disorder rather than acknowledging the existence of the illness. Other explanations offered by physicians included anxiety disorders or simply stating that the symptoms were psychological:
I got ME/CFS after a seriously bad case of tonsillitis at 20. My doctors thought it was depression and increased my antidepressants. Surprise! That didn’t help.
I’ve had ME/CFS for over twenty years. Doctors generally don’t care to hear about illnesses they don’t know how to treat. I’ve been told I’m perfectly fine, my illness is just in my head.
I have ME/CFS myself. This is a neurological disease. Since most doctors are not familiar with it, we sufferers are often labeled as mentally ill, although the symptoms are purely physical.
The third subtheme was dismissal of patients’ concerns by physicians. One commonly cited reason for this was because of the poorly understood pathophysiology of ME/CFS. Several Twitter users relayed experiences of not being believed by health care providers:
Example number 579 why the “Golden Girls” were light years ahead of its time: the episode where Dorothy has Chronic Fatigue Syndrome. The dismissing of her legitimate medical complaints as simple aging or lack of social life by doctors who can’t find an easy diagnosis is spot on!
I developed ME/CFS 8 years ago. It has absolutely devastated my life & the real kicker is NO Duke doctors I’ve seen have a clue how to treat/support me or don’t believe in it at all. Being disabled is extremely hard but to be gaslit & dismissed makes it so much worse.
The fourth subtheme focused on the need for patient self-advocacy to find “good” physicians or to receive appropriate treatment. Within this theme, some Twitter users advocated withholding their diagnosis of ME/CFS from their physicians to receive adequate care:
Most doctors are not your friend if you have ME/CFS. Don’t see them for that. See them for symptoms, never mention ME/CFS. They cannot help with that.
I’m super relieved (in disbelief) that after seeing a dozen+ doctors/specialists, I’ve found one who’s actually assessing my ME/CFS and POTS! Like looking at my symptoms, considering possible diagnoses and causes, and starting me on an initial treatment - *jaw on the floor*.
Theme 3: Research
In total, 3 subthemes were identified among tweets discussing research (Table S3 in
). The first subtheme centered on the dissemination of research, with Twitter users sharing links to articles or citing recent literature. Tweets typically focused on research supporting physical causes of ME/CFS, and medical treatments, with some suggesting evidence supporting a biomedical model of ME/CFS was vulnerable to suppression:New research linking chronic fatigue syndrome to retrovirus is released after being held by journal.
The second subtheme focused on criticism of research, particularly studies that found support for management of ME/CFS with psychotherapy or graduated exercise. Furthermore, some Twitter users speculated that some ME/CFS researchers were involved in manipulating research output:
The #PACE study claimed that graded exercise training (GET) and cognitive behavioral therapy (CBT) were effective in treating Myalgic Encephalomyelitis. There were so many things wrong with this study that it’s being used as an example of how NOT to do research.
That man I have permanently blocked. He claims to be an ME/CFS researcher. Almost all of them are corrupt and get paid to keep ME/CFS patients from finding out they likely are vaccine injured or sick as a result of a post-infectious gain of function virus.
The third subtheme involved calls for increased funding for ME/CFS research. Some Twitter users compared the relatively small amounts of funding allocated to ME/CFS versus other conditions to underscore the need for increased funding:
We need massive research programmes into both long Covid and ME/CFS, coupled with better information for doctors. But above all, we need something that currently seems a long way off. A government that gives a damn.
ME/CFS research is severely underfunded. Current NIH Funding: ME/CFS has $13 million in active NIH awards. HIV/AIDS has $3294 million in active NIH awards.
Theme 4: UK NICE Guidelines for Diagnosis and Management of ME/CFS
We identified 6 subthemes that discussed different aspects of the UK NICE guidelines for ME/CFS (Table S4 in
). The first subtheme focused on perceived problems with research used to inform the initial 2007 NICE guidelines. Much of this criticism focused on the PACE (Pacing, graded Activity, and Cognitive behavior therapy: a randomized Evaluation) trial, which randomized 641 patients diagnosed with ME/CFS to either pacing, CBT, GET, or specialist medical care, and found that CBT and GET were more effective than pacing or specialist medical care for reducing fatigue and improving physical functioning [ ]:The PACE trial which has subsequently informed NICE guidelines on treatment for ME/CFS is a great example of completely ignoring the patient voice, as well as dubious research ethics (yet is still up on the Lancet).
The problem is the broad definition of ME/CFS in PACE. It makes results fairly meaningless. NICE guidelines are the problem. They treat PACE as more powerful evidence than it is. Let’s fight to change NICE in light of new evidence. A warning for GET.
The second subtheme focused on comments suggesting that changes to the UK NICE guidelines were the result of prolonged efforts by the ME/CFS community. Specifically, how the guideline was changed to revise recommendations in favor of GET and CBT after pressure from patient advocacy groups:
Many thanks to everyone who signed this petition below re removal of GET & CBT from NICE Guidelines. We’ve reached 10,000, let’s keep it going and get to 15,000.
The updated NICE guidelines for ME/CFS are out. GET is gone (which is an absolute triumph) and CBT is now a coping strategy not a treatment. I’ll take that as a win.
We worked with ForwardME to ensure this guideline was led by #pwme.
The new NICE guidelines on ME/CFS that recommend patients stay active within their safe limits was generally welcomed by patients and a petition in support of its publication received 23,000 signatures.
The third subtheme comprised tweets indicating that the 2021 UK NICE guidelines now recognized ME/CFS as a biological disease. There were several references to the 2007 NICE guideline that was perceived as supporting ME/CFS as a psychological condition, and that the 2021 update had reversed this position:
ME/CFS is placed under the Neurological Conditions section on the NICE guideline.
The recent NICE guidelines have reversed previous statements about [ME/CFS] being psychological and now acknowledge that it is physiological.
The fourth subtheme included tweets focused on the 2021 NICE guidelines revised recommendations for GET and CBT as management options for individuals with ME/CFS:
Current NICE guidelines: The results show clearly that cognitive behavioural therapy and graded exercise therapy are unsuitable treatments or management approaches for ME/CFS.
The 2021 NICE guidelines for #MECFS have a severity box that outlines the situation.... “People with severe ME/CFS are unable to do any activity for themselves or can carry out minimal daily tasks only (such as face washing or cleaning teeth).”
The newly released NICE guidelines for ME/CFS is very firm about rejecting hysteria-based GET, CBT & The Lightening Process.
The fifth subtheme focused on the need to promote and defend the 2021 NICE ME/CFS guidelines. Several comments acknowledged that there was competing evidence regarding the role of CBT and GET and advised that promotion of the 2021 NICE guidelines was critical to ensure these interventions were not offered to patients:
The people who built their careers on disabling, torturing...even killing ME/CFS patients are extremely powerful in the UK and were not going to accept this [the new NICE guidelines] because they would have to admit their fraud. So they have decided to play dirty.
I just bloody knew it. Medical professionals are going to ignore nice guidelines and rebrand GET, CBT, to try to continue pushing us down the wrong road. Be careful everyone with #ME/CFS. WATCH OUT for anything like, improving activities, gradual activity increase, etc.
The @MEAssociation has been contacting NHS trusts that still recommend CBT and GET as treatments for #MECFS, in contradiction to the 2021 NICE guideline.
The sixth subtheme included tweets advocating that the 2021 NICE ME/CFS guideline would also benefit individuals with PCC. Specifically, many tweets discussed how the revised guidelines should be used to avoid CBT and GET for individuals with PCC:
Let’s hope the recent NICE guidelines changes on ME/CFS protect those with Long Covid from going through the hell that people with ME/CFS have gone through in terms of gaslighting and medical abuse.
I am sure the CBT/GET services and researchers are worried about losing ME/CFS patients with the review of the NICE guidelines on ME/CFS. They will look to the #longcovid patients to mitigate the loss.
Theme 5: PCC
The fifth theme that emerged was the association between ME/CFS and PCC, within which 6 subthemes were identified (Table S5 in
).The first subtheme included tweets that focused on a common biological cause between PCC and ME/CFS, although hypotheses were highly variable ranging from immunopathology, micro clots, brain stem malfunction, chronic inflammation, respiratory muscle dysfunction, and mitochondrial aberrations, among others. Relatedly, the second subtheme included tweets that focused on the erroneous attribution of PCC and ME/CFS symptoms to psychological causes:
The inner lining of blood vessels (the endothelium) plays a crucial role in maintaining cardiovascular health. A recent study found that individuals with ME/CFS and those with long COVID had significantly impaired endothelial function.
QUACK psychiatrists who have been harming patients for decades. Stop this, just stop it. Haven’t you harmed enough myalgic encephalomyelitis patients? Do you need to damage more people who have Long Covid with the same garbage psychobabble?
In terms of Long Covid and ME/CFS, there’s definitely a concerted effort on the part of some powerful people to deny, minimise and psychologise. Which allows people to believe that recovery is possible, if you have the right attitude.
The third subtheme included tweets that focused on the notion that if more research had been pursued for ME/CFS, we would now have effective treatments for PCC. The fourth subtheme comprised tweets that related to beliefs that the current attention given to PCC would likely benefit patients with ME/CFS, given the substantial overlap between these conditions:
If governments around the world had allocated more than a pittance to biomedical ME/CFS research over decades, the Long COVID fallout might not have been so severe.
There’s a huge overlap between ME/CFS and Long COVID. If only people had cared decades ago to look into ME/CFS we might have had answers for Long COVID people.
I hate to say it...but long covid is kind of a gift for us with me/cfs, because it has increased funding.
The fifth subtheme referred to warnings to avoid exercise and psychotherapy for the management of PCC and ME/CFS. Several tweets relied on the 2021 NICE guidelines for support:
Unless you have ME/CFS or Long Covid, in which case exercise can take you into total incapacity with severe intractable pain lasting for decades. Minimise exertion, rest, rest, rest.
Walking and running do not treat the underlying issue with ME/CFS or Long Covid. See NICE warning about graded exercise for LC patients and draft guidelines which say exercise should not be prescribed to ME/CFS sufferers.
The sixth subtheme comprised tweets that suggested that there was no cure for PCC or ME/CFS:
If what you have is Long Covid going on to ME/CFS, stay at home and rest, take care of yourself. There is no effective medical treatment, nothing that a doctor can give you that can make you better.
I’ve been existing with ME/CFS for the past 29 years. It’s a post-viral disease I got from Epstein Barr Virus (Mono). It’s a living death. I’ve now had Long COVID since March of 2020. It’s also a post-viral ME/CFS-like disease. There’s no treatments nor cures.
Discussion
Principal Findings
We found Twitter to be an active forum for discussions regarding ME/CFS, with most tweets being either neutral or negative in their sentiments. Increases in both positive and negative tweets occurred after the release of the 2021 NICE guidelines for the diagnosis and management of ME/CFS and after the onset of the COVID-19 pandemic. Common themes included treatment and symptoms of ME/CFS, fibromyalgia, research, and (after the pandemic) PCC. Our thematic analysis identified acknowledgment of considerable overlap in symptoms between fibromyalgia, ME/CFS and PCC; frustration with dismissal by physicians and labeling of these conditions as psychological; and a desire for research that identified physical causes and biomedical treatments for ME/CFS. There was considerable enthusiasm for the 2021 NICE guidelines that reversed the prior recommendation in favor of GET, claims that revisions were the result of patient advocacy efforts, and claims that both ME/CFS and PCC were lifelong conditions without effective treatments or cures.
This is the first study to analyze public sentiment regarding ME/CFS on Twitter. People living with ME/CFS browse the web up to 10-fold more often than individuals living with other chronic conditions to connect with other patients and share experiences [
]. Previous studies have confirmed the overlap in symptoms between people living with fibromyalgia and those diagnosed with ME/CFS [ ], with some investigators suggesting that labels assigned to patients may be largely an artifact of medical specialization [ ].Unfortunately, several studies have found that, due to a lack of objective diagnostic markers, people living with ME/CFS often perceive stigmatization and experience delegitimizing practices by physicians [
, ]. These experiences may have clinical implications, as a recent systematic review found that stigma is associated with increased pain intensity, disability, and depression among people living with chronic pain [ ]. Conversely, physician empathy has been associated with improved outcomes [ , ]. People living with ME/CFS typically report low satisfaction with physician encounters [ - ], often due to the perception that physicians are inadequately trained to manage their concerns and often attribute symptoms to psychological issues [ ]. These experiences are consistent with studies of physicians reporting that one-third to half of general practitioners do not accept ME/CFS as a genuine clinical entity and, among those who do, many lack confidence in diagnosis and management [ ].ME/CFS research is a contentious topic as, although 4 decades of study since case definitions of ME and CFS were published in the mid-to-late 1980s [
], a biomedical cause or biomarkers of disease remain elusive. Prospective studies that control for ascertainment bias have failed to show an association between acute infection and development of ME/CFS [ ]. In contrast, several studies have found associations between the onset of ME/CFS and elevated premorbid stress, psychopathology, severe life events, or difficulties [ , ]. These findings should not be construed as evidence that symptoms associated with ME/CFS are not real, but as support that the central nervous systems’ response to biological, psychological, and social factors may be more likely to explain symptoms versus a specific disease process [ ]. However, our findings suggest this paradigm may be unacceptable to many people living with ME/CFS.Similar issues appear to have complicated the acceptance of some interventional studies and the development of clinical practice guidelines. The largest randomized controlled trial to explore the management of ME/CFS is the PACE trial [
]; however, the finding that CBT and GET provided benefits for fatigue and physical function at both 1 and 2-year follow-up [ ] is contentious for many patients and advocacy groups [ ]. The ME Association recommended that NICE withdraw their recommendation for GET and that CBT should not be a primary intervention for ME/CFS, and a petition to retract the PACE trial received over 10,000 signatures from patients [ ]. Our analysis of tweets also found several mentions of a prolonged campaign to pressure the 2007 UK NICE guidelines’ authors to remove recommendations in favor of CBT and GET, which were modified in the second version released in 2021 ( ).2007 NICE myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) guideline
- “Cognitive behavioural therapy (CBT) and/or graded exercise therapy (GET) should be offered to people with mild or moderate CFS/ME and provided to those who choose these approaches, because currently these are the interventions for which there is the clearest research evidence of benefit.”
2021 NICE ME/CFS guidelines
- “Do not offer people with ME/CFS any program…that uses fixed incremental increases in physical activity or exercise, for example, graded exercise therapy”
- “Only offer CBT to adults, children and young people with ME/CFS if, after discussing it, they would like to use it to support them in managing their symptoms…Explain that CBT for people with ME/CFS does not assume people have ‘abnormal’ illness beliefs and behaviours as an underlying cause of their ME/CFS, but recognises that thoughts, feelings, behaviours and physiology interact with each other.”
The updated NICE guidance justified changes in recommendations regarding CBT and GET for 4 reasons. First, by downgrading the evidence for indirectness because trials that provided supporting evidence did not require patients to screen positive for postexertional malaise (PEM), even though treatment effects were similar across patients with different diagnostic criteria (including those with PEM). Second, they rejected evidence from randomized trials that found GET was not harmful in favor of anecdotal reports by patients that GET worsened their symptoms. Third, they considered outcomes at the longest follow-up reported, which for the PACE trial meant results were confounded by cross-over. Finally, the guideline panel rejected evidence from Cochrane reviews because they did not report on mortality—an outcome that Cochrane review authors did not view as relevant for trials of CBT or GET [
].Our analysis suggests the updated NICE guideline was well-received by patients and may be associated with the increase in positive tweets at this time. However, 4 members of the 2021 NICE guideline development committee resigned in protest [
], representatives of 7 UK medical groups (including the Royal College of Physicians) signed a joint statement relaying concerns with the guideline [ ], and more than 50 international specialists analyzed the guideline and concluded that “the consequences of this are that patients may be denied helpful treatments and therefore risk persistent ill health and disability” [ ]. At present, there are at least 2 ongoing campaigns by ME/CFS advocacy groups to have other publications they disagree with retracted: a Cochrane review that found GET was helpful for ME/CFS [ ] and a deep phenotyping study of patients with ME/CFS that found functional limitations were due to “altered effort preference” [ ].Mention of PCC in tweets made after the onset of the pandemic aligns with studies that have shown a large overlap in symptoms between this condition and ME/CFS [
]. Interest by patients with ME/CFS may also be driven by the renewed attention to postinfectious fatigue syndromes that PCC has generated and resulting new investments in research. For example, the US NIH recently committed US $1 billion to fund PCC research [ ]. Patients with a diagnosis of PCC face similar issues as patients with ME/CFS. Female sex and psychological factors are risk factors for developing PCC [ , ], infection with COVID-19 may not be required to manifest symptoms of PCC [ ], and CBT and graduated exercise [ ] are emerging as promising therapies. A Twitter sentiment analysis of 814,951 tweets on PCC also found key topics included calls for more research and better treatments [ ].The notion that recovery from ME/CFS is not possible is inconsistent with the evidence. Although only 5% of patients experience full recovery without targeted intervention [
], observational studies have reported a recovery rate of 18% following CBT [ , ]. There are entire organizations dedicated to recovered patients, such as Recovery Norge [ ]. Interviews with patients who have fully recovered from ME/CFS reveal a consistent pattern of engagement with graduated exercise and psychotherapy to increase self-agency [ , ]. Furthermore, recovery from ME/CFS is associated with not attributing illness to a physical cause and a greater sense of control over symptoms [ ]. However, patients who achieve recovery report conflicts with patients who have not, including skepticism about whether they had ME/CFS. Once patients recover from ME/CFS, they are less likely to remain engaged with online support groups [ ].Strengths and Limitations
Strengths of our study include a large dataset of almost 1 million tweets. In addition, we performed sentiment analysis with a RoBERTa model, which has previously been trained on 58 million tweets. Finally, we ensured that representative subthemes were identified by independent raters which increases confidence in the reliability of our findings.
Our study also has several limitations. The method of tweet collection relied on a list of search terms that may have missed some relevant tweets and NLP models can misinterpret the sentiment of tweets, particularly when sarcasm is used [
]. As NLP methods evolve, it may become possible to harness the power of GPT models to facilitate more accurate sentiment, emotional, and thematic analyses. Discussions surrounding PCC in the post-UK NICE publication dataset may have suffered from some confounding with the post–COVID-19 pandemic dataset due to the overlap in dates, particularly because PCC was identified relatively late into the pandemic. In addition, demographics, geographic location, and previous daily activities of the authors of text-based social media data can result in different word choices even when discussing the same subject matter [ - ], and we were unable to adjust for these factors.Implications
Our findings highlight several important issues. First, although current evidence supports exercise therapy [
] and CBT [ ] for the management of ME/CFS, some patients find these approaches unacceptable. In part, due to concerns about harm (eg, PEM following GET) and stigmatization (with CBT). Further research is needed to inform how best to support patients’ engagement with evidence-based care. Second, patients often report unsatisfactory health care encounters leading to disengagement and a desire to attend clinicians that view ME/CFS as purely physical disorder. For example, some surgeons offer cranial and spinal decompression as a treatment for ME/CFS [ ], despite a lack of evidence supporting this approach. These findings reinforce the importance of building therapeutic relationships with patients living with ME/CFS that include addressing possible concerns about mind-body treatment approaches. Patients who view their health care provider as sympathetic may be more willing to engage in shared decision-making about interventions they are considering.Third, our findings with respect to the potential influence of advocacy efforts on science are especially critical given the increasingly recognized importance of including patient partners in research [
]. Involvement of patient partners can improve the quality and relevance of research efforts [ ]; however, participants with important intellectual conflicts of interest can compromise the research process and reduce the trustworthiness of results [ ]. Finally, ME/CFS is not the first postinfectious syndrome, and will not be the last [ ]. The latest variant is PCC, which, at present, is the focus of considerable attention and research funding. This presents important opportunities to advance our understanding of the etiology, prognosis, and effective management of this disorder. Such efforts would be more valuable if they considered the degree to which results may be generalizable to postinfectious fatigue syndromes in general.Future Directions
Twitter is an important source of information and communication for people living with ME/CFS. The degree to which advice is credible and consistent with the current best evidence is therefore important [
]. Our findings suggest that some individuals living with ME/CFS who post on Twitter believe that GET is harmful, CBT is ineffective, and recovery is not possible. Efforts should be made to promote the dissemination of evidence-based information on Twitter and assist patients in assessing the credibility of statements made on social media. Removing hope of improvement or recovery from ME/CFS can have dire consequences for some patients [ - ]. A survey of members of the Canadian Association of Medical Assistance in Dying Assessors and Providers found that ME/CFS was the second most common nonfatal condition for which medical assistance in dying was requested [ ].Acknowledgments
The authors thank Rachel J Couban, medical librarian, for their advice and assistance in selecting our Twitter search terms and formatting our references. This study was funded through an anonymous donor via the McMaster University Trust. JWB is supported, in part, by the Canadian Institutes of Health Research Canada Research Chair in the Prevention and Management of Chronic Pain.
Data Availability
The code used to generate these analyses is available on GitHub [
]. The datasets generated during this study are available from the corresponding author on reasonable request.Authors' Contributions
JWB conceptualized the study, acquired funding, contributed to the methodology, provided resources, supervised the project, and contributed to the writing of the original manuscript and subsequent editing. IK, JG, and FZ contributed to data curation, performed data analysis, helped develop methodology, contributed to visualization, and helped with writing and editing of the manuscript. SJ and BD also contributed to the writing and editing of the manuscript. CL, WA, and DZ contributed to the review and editing of the manuscript. All authors have read and agreed to the published version of the manuscript.
Conflicts of Interest
None declared.
Additional details on tweet retrieval and analysis.
DOCX File , 7078 KBReferences
- Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC. The National Academies Press; 2015.
- Sandler CX, Lloyd AR. Chronic fatigue syndrome: progress and possibilities. Med J Aust. May 2020;212(9):428-433. [CrossRef] [Medline]
- Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SH, Son CG. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Transl Med. Feb 24, 2020;18(1):100. [FREE Full text] [CrossRef] [Medline]
- Myalgic encephalomyelitis/chronic fatigue syndrome. US Centers For Disease Control And Prevention. May 10, 2024. URL: https://www.cdc.gov/me-cfs/hcp/diagnosis-testing/factors-complicating-the-diagnosis-of-me-cfs.html [accessed 2024-12-24]
- Froehlich L, Hattesohl DB, Cotler J, Jason LA, Scheibenbogen C, Behrends U. Causal attributions and perceived stigma for myalgic encephalomyelitis/chronic fatigue syndrome. J Health Psychol. Sep 2022;27(10):2291-2304. [FREE Full text] [CrossRef] [Medline]
- Kingdon C, Lowe A, Shepherd C, Nacul L. What primary care practitioners need to know about the new NICE guideline for myalgic encephalomyelitis/chronic fatigue syndrome in adults. Healthcare (Basel). Dec 02, 2022;10(12):2438. [FREE Full text] [CrossRef] [Medline]
- Dehlia A, Guthridge MA. The persistence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) after SARS-CoV-2 infection: a systematic review and meta-analysis. J Infect. Dec 2024;89(6):106297. [FREE Full text] [CrossRef] [Medline]
- Moneer O. Long COVID, ME/CFS and the importance of studying infection-associated illnesses. Yale Medicine. May 13, 2024. URL: https://www.yalemedicine.org/news/long-covid-mecfs-and-the-importance-of-studying-infection-associated-illnesses [accessed 2025-04-20]
- Phillips S, Williams MA. Long Covid is a new name for an old syndrome. Stat. Sep 14, 2023. URL: https://www.statnews.com/2023/09/14/long-covid-me-cfs-myalgic-encephalomyelitis-chronic-fatigue/ [accessed 2025-04-20]
- Lavallee DC, Chenok KE, Love RM, Petersen C, Holve E, Segal CD, et al. Incorporating patient-reported outcomes into health care to engage patients and enhance care. Health Aff (Millwood). Apr 2016;35(4):575-582. [CrossRef] [Medline]
- Knudsen A, Lervik L, Harvey S, Løvvik C, Omenås A, Mykletun A. Comparison of chronic fatigue syndrome/myalgic encephalopathy with other disorders: an observational study. JRSM Short Rep. May 2012;3(5):32. [FREE Full text] [CrossRef] [Medline]
- Ytre-Arne B. The social media experiences of long-term patients: illness, identity, and participation. Nordicom Rev. 2016;37(1):57-70. [CrossRef]
- Lian OS, Nettleton S. "United we stand": framing myalgic encephalomyelitis in a virtual symbolic community. Qual Health Res. Oct 2015;25(10):1383-1394. [CrossRef] [Medline]
- Alkhaldi NA, Asiri Y, Mashraqi AM, Halawani HT, Abdel-Khalek S, Mansour RF. Leveraging tweets for artificial intelligence driven sentiment analysis on the COVID-19 pandemic. Healthcare (Basel). May 13, 2022;10(5):910. [FREE Full text] [CrossRef] [Medline]
- AbuRaed AG, Prikryl EA, Carenini G, Janjua NZ. Long COVID discourse in Canada, the United States, and Europe: topic modeling and sentiment analysis of Twitter data. J Med Internet Res. Dec 09, 2024;26:e59425. [CrossRef] [Medline]
- Awoyemi T, Ebili U, Olusanya A, Ogunniyi KE, Adejumo AV. Twitter sentiment analysis of long COVID syndrome. Cureus. Jun 2022;14(6):e25901. [FREE Full text] [CrossRef] [Medline]
- Wood MS, Halmer N, Bertolli J, Amsden LB, Nugent JR, Lin JM, et al. Impact of COVID-19 on myalgic encephalomyelitis/chronic fatigue syndrome-like illness prevalence: a cross-sectional survey. PLoS One. 2024;19(9):e0309810. [FREE Full text] [CrossRef] [Medline]
- Komaroff AL, Lipkin WI. ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature. Front Med (Lausanne). 2023;10:1187163. [FREE Full text] [CrossRef] [Medline]
- Das M, K S, Alphonse PJ. A comparative study on TF-IDF feature weighting method and its analysis using unstructured dataset. arXiv. Preprint posted online on August 8, 2023. [FREE Full text]
- Jelodar H, Wang Y, Yuan C, Feng X, Jiang X, Li Y, et al. Latent dirichlet allocation (LDA) and topic modeling: models, applications, a survey. arXiv. Preprint posted online on November 12, 2017. [FREE Full text] [CrossRef]
- Sokolova M, Huang K, Matwin S, Ramisch J, Sazonova V, Black R, et al. Topic modelling and event identification from Twitter textual data. arXiv. Preprint posted online on August 8, 2016. [FREE Full text]
- Boon-Itt S, Skunkan Y. Public perception of the COVID-19 pandemic on Twitter: sentiment analysis and topic modeling study. JMIR Public Health Surveill. Nov 11, 2020;6(4):e21978. [FREE Full text] [CrossRef] [Medline]
- Introduction. X Developer Platform. URL: https://docs.x.com/x-api/posts/search/introduction [accessed 2024-12-24]
- Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. National Institute for Health and Care Excellence. Oct 29, 2021. URL: https://www.nice.org.uk/guidance/ng206/chapter/Context#:~:text=NICE%20produced%20a%20guideline%20on,ME%2FCFS%20and%20health%20providers [accessed 2024-12-24]
- CDC museum COVID-19 timeline. US Centers for Disease Control and Prevention. URL: https://www.cdc.gov/museum/timeline/covid19.html [accessed 2024-12-24]
- Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. National Institute for Health and Care Excellence. 2021. URL: https://www.nice.org.uk/guidance/ng206 [accessed 2025-05-12]
- Chatla SK, Geeda SC, Pavani K, Kokkiligadda RR, Shaik MG. Comparative analysis of sentiment analysis models on Twitter data using machine learning. In: Proceedings of the Inventive Communication and Computational Technologies. 2024. Presented at: ICICCT 2024; June 14-15, 2024; Tamil Nadu, India. [CrossRef]
- Kumar B, Sheetal, Badiger VS, Jacintha AD. Sentiment analysis for products review based on NLP using lexicon-based approach and Roberta. In: Proceedings of the 2024 International Conference on Intelligent and Innovative Technologies in Computing, Electrical and Electronics. 2024. Presented at: IITCEE 2024; January 24-25, 2024; Bangalore, India. [CrossRef]
- Kotelnikova A, Paschenko D, Bochenina K, Kotelnikov E. Lexicon-based methods vs. BERT for text sentiment analysis. In: Proceedings of the 10th International Conference on Analysis of Images, Social Networks and Texts. 2022. Presented at: AIST 2021; December 16-18, 2021; Tbilisi, Georgia. [CrossRef]
- cardiffnlp / twitter-roberta-base-sentiment-latest. Hugging Face. URL: https://huggingface.co/cardiffnlp/twitter-roberta-base-sentiment-latest [accessed 2024-12-24]
- Lundberg S, Lee SI. A unified approach to interpreting model predictions. arXiv. Preprint posted online on May 22, 2017. [FREE Full text]
- shap.PartitionExplainer. SHAP. URL: https://shap.readthedocs.io/en/latest/generated/shap.PartitionExplainer.html [accessed 2024-12-24]
- Zhao W, Joshi T, Nair VN, Sudjianto A. SHAP values for explaining CNN-based text classification models. arXiv. Preprint posted online on August 26, 2020. [FREE Full text]
- zhfwen / twitter_mecfs. GitHub. URL: https://github.com/zhfwen/twitter_mecfs [accessed 2025-01-01]
- White PD, Goldsmith KA, Johnson AL, Potts L, Walwyn R, DeCesare JC, et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet. Mar 05, 2011;377(9768):823-836. [FREE Full text] [CrossRef] [Medline]
- Shortland DL, Fazil Q, Hallett N, Lavis A. Protocol for a scoping review of how people with ME/CFS use the internet. BMJ Open. Jan 29, 2024;14(1):e076904. [FREE Full text] [CrossRef] [Medline]
- Ramírez-Morales R, Bermúdez-Benítez E, Martínez-Martínez LA, Martínez-Lavín M. Clinical overlap between fibromyalgia and myalgic encephalomyelitis. A systematic review and meta-analysis. Autoimmun Rev. Aug 2022;21(8):103129. [CrossRef] [Medline]
- Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet. Sep 11, 1999;354(9182):936-939. [CrossRef] [Medline]
- Lacerda EM, McDermott C, Kingdon CC, Butterworth J, Cliff JM, Nacul L. Hope, disappointment and perseverance: reflections of people with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis participating in biomedical research. A qualitative focus group study. Health Expect. Jun 2019;22(3):373-384. [FREE Full text] [CrossRef] [Medline]
- Hickling LM, Allani S, Cella M, Scott W. A systematic review with meta-analyses of the association between stigma and chronic pain outcomes. Pain. Aug 01, 2024;165(8):1689-1701. [CrossRef] [Medline]
- Licciardone JC, Tran Y, Ngo K, Toledo D, Peddireddy N, Aryal S. Physician empathy and chronic pain outcomes. JAMA Netw Open. Apr 01, 2024;7(4):e246026. [FREE Full text] [CrossRef] [Medline]
- Timbol CR, Baraniuk JN. Chronic fatigue syndrome in the emergency department. Open Access Emerg Med. 2019;11:15-28. [FREE Full text] [CrossRef] [Medline]
- Sunnquist M, Nicholson L, Jason LA, Friedman KJ. Access to medical care for individuals with myalgic encephalomyelitis and chronic fatigue syndrome: a call for centers of excellence. Mod Clin Med Res. Apr 2017;1(1):28-35. [FREE Full text] [CrossRef] [Medline]
- Froehlich L, Hattesohl DB, Jason LA, Scheibenbogen C, Behrends U, Thoma M. Medical care situation of people with myalgic encephalomyelitis/chronic fatigue syndrome in Germany. Medicina (Kaunas). Jun 23, 2021;57(7):646. [FREE Full text] [CrossRef] [Medline]
- Tidmore TM, Jason LA, Chapo-Kroger L, So S, Brown A, Silverman MC. Lack of knowledgeable healthcare access for patients with neuro-endocrine-immune diseases. Front Clin Med. 2015;2(2):46-54. [FREE Full text]
- Pheby DF, Araja D, Berkis U, Brenna E, Cullinan J, de Korwin JD, et al. A literature review of GP knowledge and understanding of ME/CFS: a report from the socioeconomic working group of the European Network on ME/CFS (EUROMENE). Medicina (Kaunas). Dec 24, 2020;57(1):7. [FREE Full text] [CrossRef] [Medline]
- Ramsey AM, David AS, Wessely S, Pelosi AJ, Dowsett EG. Myalgic encephalomyelitis, or what? The Lancet. Jul 1988;332(8602):100-101. [CrossRef]
- Wessely S, Chalder T, Hirsch S, Pawlikowska T, Wallace P, Wright DJ. Postinfectious fatigue: prospective cohort study in primary care. Lancet. May 27, 1995;345(8961):1333-1338. [CrossRef] [Medline]
- Hatcher S, House A. Life events, difficulties and dilemmas in the onset of chronic fatigue syndrome: a case-control study. Psychol Med. Oct 2003;33(7):1185-1192. [FREE Full text] [CrossRef] [Medline]
- Kato K, Sullivan PF, Evengård B, Pedersen NL. Premorbid predictors of chronic fatigue. Arch Gen Psychiatry. Nov 2006;63(11):1267-1272. [CrossRef] [Medline]
- Oslo Chronic Fatigue Consortium, Alme TN, Andreasson A, Asprusten TT, Bakken AK, Beadsworth MB, et al. Chronic fatigue syndromes: real illnesses that people can recover from. Scand J Prim Health Care. Dec 2023;41(4):372-376. [FREE Full text] [CrossRef] [Medline]
- Sharpe M, Goldsmith KA, Johnson AL, Chalder T, Walker J, White PD. Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial. Lancet Psychiatry. Dec 2015;2(12):1067-1074. [CrossRef] [Medline]
- Wilshire CE, Kindlon T, Courtney R, Matthees A, Tuller D, Geraghty K, et al. Rethinking the treatment of chronic fatigue syndrome-a reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT. BMC Psychol. Mar 22, 2018;6(1):6. [FREE Full text] [CrossRef] [Medline]
- Shepherd C. Patient reaction to the PACE trial. Lancet Psychiatry. Feb 2016;3(2):e7-e8. [CrossRef] [Medline]
- Flottorp SA, Brurberg KG, Fink P, Knoop H, Wyller VB. New NICE guideline on chronic fatigue syndrome: more ideology than science? Lancet. Feb 12, 2022;399(10325):611-613. [CrossRef] [Medline]
- Torjesen I. Exclusive: four members of NICE's guideline committee on ME/CFS stand down. BMJ. Aug 03, 2021;374:n1937. [CrossRef] [Medline]
- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): joint statement in response to NICE guidance on ME/CFS. Royal College of General Practitioners. URL: https://www.rcgp.org.uk/representing-you/policy-areas/guidance-on-me-cfs [accessed 2024-12-24]
- White P, Abbey S, Angus B, Ball HA, Buchwald DS, Burness C, et al. Anomalies in the review process and interpretation of the evidence in the NICE guideline for chronic fatigue syndrome and myalgic encephalomyelitis. J Neurol Neurosurg Psychiatry. Dec 2023;94(12):1056-1063. [CrossRef] [Medline]
- Candish M. Cochrane: withdraw the harmful 2019/2024 exercise therapy for CFS review. Change.org. URL: https://www.change.org/p/cochrane-withdraw-the-harmful-2019-exercise-therapy-for-cfs-review [accessed 2024-12-24]
- NIH clinical study: a case of continued institutional bias. MEadvocacy. URL: https://www.meadvocacy.org/nih_clinical_study_a_case_of_continued_institutional_bias [accessed 2024-12-24]
- Subbaraman N. US health agency will invest $1 billion to investigate 'long COVID'. Nature. Mar 2021;591(7850):356. [CrossRef] [Medline]
- Maglietta G, Diodati F, Puntoni M, Lazzarelli S, Marcomini B, Patrizi L, et al. Prognostic factors for post-COVID-19 syndrome: a systematic review and meta-analysis. J Clin Med. Mar 11, 2022;11(6):1541. [FREE Full text] [CrossRef] [Medline]
- Notarte KI, de Oliveira MH, Peligro PJ, Velasco JV, Macaranas I, Ver AT, et al. Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for Long COVID-19: a systematic review and meta-analysis. J Clin Med. Dec 09, 2022;11(24):7314. [FREE Full text] [CrossRef] [Medline]
- Matta J, Wiernik E, Robineau O, Carrat F, Touvier M, Severi G, et al. Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern Med. Jan 01, 2022;182(1):19-25. [FREE Full text] [CrossRef] [Medline]
- Kuut TA, Müller F, Csorba I, Braamse A, Aldenkamp A, Appelman B, et al. Efficacy of cognitive-behavioral therapy targeting severe fatigue following coronavirus disease 2019: results of a randomized controlled trial. Clin Infect Dis. Sep 11, 2023;77(5):687-695. [FREE Full text] [CrossRef] [Medline]
- Cairns R, Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup Med (Lond). Jan 2005;55(1):20-31. [CrossRef] [Medline]
- Flo E, Chalder T. Prevalence and predictors of recovery from chronic fatigue syndrome in a routine clinical practice. Behav Res Ther. Dec 2014;63:1-8. [FREE Full text] [CrossRef] [Medline]
- Adamson J, Ali S, Santhouse A, Wessely S, Chalder T. Cognitive behavioural therapy for chronic fatigue and chronic fatigue syndrome: outcomes from a specialist clinic in the UK. J R Soc Med. Oct 2020;113(10):394-402. [FREE Full text] [CrossRef] [Medline]
- Recovery Norway. URL: https://www.recoverynorway.org/ [accessed 2025-05-12]
- Hasan Z, Kuyvenhoven C, Chowdhury M, Amoudi L, Zeraatkar D, Busse JW, et al. Patient perspectives of recovery from myalgic encephalomyelitis/chronic fatigue syndrome: an interpretive description study. J Eval Clin Pract. Mar 2024;30(2):234-242. [CrossRef] [Medline]
- Bakken AK, Mengshoel AM, Synnes O, Strand EB. Acquiring a new understanding of illness and agency: a narrative study of recovering from chronic fatigue syndrome. Int J Qual Stud Health Well Being. Dec 2023;18(1):2223420. [FREE Full text] [CrossRef] [Medline]
- Friedberg F, Leung DW, Quick J. Do support groups help people with chronic fatigue syndrome and fibromyalgia? A comparison of active and inactive members. J Rheumatol. Dec 2005;32(12):2416-2420. [Medline]
- A A, G S, H R S, Upadhyaya M, Ray AP, T C M. Sarcasm detection in natural language processing. Mater Today Proc. 2021;37:3324-3331. [CrossRef]
- Mitchell L, Frank MR, Harris KD, Dodds PS, Danforth CM. The geography of happiness: connecting Twitter sentiment and expression, demographics, and objective characteristics of place. PLoS One. 2013;8(5):e64417. [FREE Full text] [CrossRef] [Medline]
- Padilla JJ, Kavak H, Lynch CJ, Gore RJ, Diallo SY. Temporal and spatiotemporal investigation of tourist attraction visit sentiment on Twitter. PLoS One. 2018;13(6):e0198857. [FREE Full text] [CrossRef] [Medline]
- Gore RJ, Diallo S, Padilla J. You are what you tweet: connecting the geographic variation in America's obesity rate to Twitter content. PLoS One. 2015;10(9):e0133505. [FREE Full text] [CrossRef] [Medline]
- Larun L, Brurberg KG, Odgaard-Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst Rev. Apr 25, 2017;4(4):CD003200. [FREE Full text] [CrossRef] [Medline]
- Smith ME, Haney E, McDonagh M, Pappas M, Daeges M, Wasson N, et al. Treatment of myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review for a national institutes of health pathways to prevention workshop. Ann Intern Med. Jun 16, 2015;162(12):841-850. [FREE Full text] [CrossRef] [Medline]
- Burton TM. Some doctors operate on people diagnosed with chronic fatigue. Wall Street Journal. Nov 11, 1999. URL: https://www.wsj.com/articles/SB942280927444238502 [accessed 2025-05-07]
- Richards DP. Dear sceptics of patient engagement in research. BMJ. Jan 22, 2025;388:r133. [CrossRef] [Medline]
- Domecq JP, Prutsky G, Elraiyah T, Wang Z, Nabhan M, Shippee N, et al. Patient engagement in research: a systematic review. BMC Health Serv Res. Feb 26, 2014;14:89. [FREE Full text] [CrossRef] [Medline]
- Guyatt G, Akl EA, Hirsh J, Kearon C, Crowther M, Gutterman D, et al. The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med. Jun 01, 2010;152(11):738-741. [FREE Full text] [CrossRef] [Medline]
- Wessely S. Old wine in new bottles: neurasthenia and 'ME'. Psychol Med. Feb 1990;20(1):35-53. [CrossRef] [Medline]
- Alamoodi AH, Zaidan BB, Zaidan AA, Albahri OS, Mohammed KI, Malik RQ, et al. Sentiment analysis and its applications in fighting COVID-19 and infectious diseases: a systematic review. Expert Syst Appl. Apr 01, 2021;167:114155. [FREE Full text] [CrossRef] [Medline]
- Dahir I. ‘My last day will be on Saturday’: 28-year-old with ME shares final post before being euthanised. Yahoo News. Jan 31, 2024. URL: https://uk.news.yahoo.com/euthanasia-netherlands-young-woman-me-160503238.html [accessed 2024-12-24]
- My sister euthanized herself. She shouldn't have had to do it the way she did. X Corp. 2024. URL: https://x.com/Slate/status/1770974572935799097 [accessed 2024-12-24]
- My friend chose an assisted death in Switzerland. Her dying wish was to tell you why. Pegasos Swiss Association. URL: https://pegasos-association.com/news/my-friend-chose-an-assisted-death-in-switzerland-her-dying-wish-was-to-tell-you-why/ [accessed 2024-12-24]
- Summers L. There is no help – final message of woman with ME. BBC. Jul 29, 2024. URL: https://www.bbc.com/news/articles/c51y7zq4pgno [accessed 2024-12-24]
- Wiebe E, Kelly M. Medical assistance in dying when natural death is not reasonably foreseeable: survey of providers' experiences with patients making track 2 requests. Can Fam Physician. Dec 2023;69(12):853-858. [FREE Full text] [CrossRef] [Medline]
Abbreviations
API: application programming interface |
BERT: Bidirectional Embedding Representations from Transformers |
CBT: cognitive behavioral therapy |
CFS: chronic fatigue syndrome |
GET: graded exercise therapy |
LDA: latent Dirichlet allocation |
ME: myalgic encephalomyelitis |
NICE: National Institute for Health and Care Excellence |
NIH: National Institutes of Health |
NLP: natural language processing |
PACE: Pacing, graded Activity, and Cognitive behavior therapy: a randomized Evaluation PCC: post-COVID-19 condition |
PEM: postexertional malaise |
RoBERTa: Robustly Optimized Bidirectional Embedding Representations from Transformers Pretraining Approach |
SHAP: Shapley Additive Explanations |
Edited by A Schwartz; submitted 05.08.24; peer-reviewed by R Gore, A Rasool, K Dashtipour; comments to author 10.12.24; revised version received 28.03.25; accepted 04.05.25; published 21.05.25.
Copyright©Iliya Khakban, Shagun Jain, Joseph Gallab, Blossom Dharmaraj, Fangwen Zhou, Cynthia Lokker, Wael Abdelkader, Dena Zeraatkar, Jason W Busse. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 21.05.2025.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research (ISSN 1438-8871), is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.